Ovarian Cancer represents the fourth leading
cause of cancer deaths in women in the United States
and is the most fatal gynecological malignancy.
Unfortunately, because of factors such as the lack
of early detection methods and the difficult accessibility
of the ovary, the pathogenesis of this disease is
not well understood. UAB's Ovarian Cancer SPORE
focuses on the areas of Chemoprevention, Gene Therapy,
and Targeted Immunotherapy.